{
    "nctId": "NCT06006299",
    "briefTitle": "Investigating the Use of TaVNS to Treat Insomnia in Individuals with Breast Cancer (taVNS-insomnia-BC)",
    "officialTitle": "Investigating the Feasibility of Using TaVNS to Treat Insomnia in Individuals with Stage I-IV Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Insomnia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Feasibility of using transauricular Vagus Nerve Stimulation to treat insomnia in individuals with stage I-IV breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. at least 18 years of age\n2. diagnosed stage I-IV breast cancer\n3. self-reported difficulty falling asleep, staying asleep, or waking up too early, for at least three nights per week for a duration of at least three months\n4. beginning or worsening of sleep disturbance since cancer diagnosis (did your sleep problems begin or get worse with the diagnosis of cancer or with chemotherapy?)\n5. English-speaking\n\nExclusion Criteria:\n\n1. Are using a daily sleep aid except melatonin (use of a sleep aid as needed will be permitted, and use will be noted).\n2. have a history of severe mental illness\n3. have an implanted medical device of any type\n4. have a history of seizures\n5. have peripheral neuropathy including temporal mandibular disorders and Bells Palsy\n6. have vasovagal syncope\n7. have moderate to severe cognitive impairment\n8. have \\<6 months to live as determined by the physician",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}